The four ages of Down syndrome

被引:312
作者
Bittles, Alan H.
Bower, Carol
Hussain, Rafat
Glasson, Emma J.
机构
[1] Edith Cowan Univ, Ctr Human Genet, Perth, WA 6027, Australia
[2] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia
[3] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
[4] King Edward Mem Hosp, WA Birth Defects Registry, Perth, WA, Australia
[5] Univ New England, Sch Hlth, Armidale, NSW, Australia
[6] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia
基金
英国医学研究理事会;
关键词
comorbidity; data linkage; Down syndrome; life expectancy; life stages; mortality;
D O I
10.1093/eurpub/ckl103
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Down syndrome (DS) affects similar to 1 per 650-1000 live births and is the most common known genetic cause of intellectual disability. A highly significant change in the survival of people with DS has occurred during the last two generations, with life expectancy estimates increasing from 12 to nearly 60 years of age. Subjects and Methods: Detailed information on 1332 people in Western Australia with DS was abstracted from a specialist statewide database for the period 1953-2000 and electronically linked with three other state or national health and mortality data sources and the state Birth Defects Registry. Results: Over the last 25 years the percentage of women over 35 years giving birth increased from 4.8 to 18.6%, accompanied by an increase in the overall prevalence of DS from 1.1 to 2.9 per 1000 births. Four life stages of DS were identified: prenatal, childhood and early adulthood, adulthood, and senescence. Although pneumonia, or other types of respiratory infections, was the most common cause of death across the entire lifespan, ranging from 23% of deaths in adulthood to 40% in senescence, each life stage exhibited a particular profile of comorbidities. Congenital heart defects were common causes in childhood (13%) and adulthood (23%), whereas in senescence coronary artery disease (10%) and cardiac, renal, and respiratory failure (9%) were leading causes of mortality. Conclusions: A major re-appraisal in attitudes towards DS is required to ensure that the medical and social needs of people with the disorder are adequately met across their entire lifespan. In particular, specific recognition of the comorbidities that can arise at different ages is needed, accompanied by the provision of appropriate levels of care and management.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 78 条
[1]  
*AM I HLTH WELF, NAT DEATH IND
[2]   LIFE EXPECTANCY IN DOWN-SYNDROME [J].
BAIRD, PA ;
SADOVNICK, AD .
JOURNAL OF PEDIATRICS, 1987, 110 (06) :849-854
[3]   Down's syndrome: occurrence and outcome in the north of England, 1985-99 [J].
Bell, R ;
Rankin, J ;
Donaldson, LJ .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2003, 17 (01) :33-39
[4]   Down's syndrome protects against breast cancer:: Is a constitutional cell microenvironment the key? [J].
Bénard, J ;
Béron-Gaillard, N ;
Satgé, D .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (01) :168-170
[5]   Clinical, social, and ethical implications of changing life expectancy in Down syndrome [J].
Bittles, AH ;
Glasson, EJ .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2004, 46 (04) :282-286
[6]   The influence of intellectual disability on life expectancy [J].
Bittles, AH ;
Petterson, BA ;
Sullivan, SG ;
Hussain, R ;
Glasson, EJ ;
Montgomery, PD .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2002, 57 (07) :M470-M472
[7]  
BOWER C, 2003, REPORT BIRTH DEFECTS
[8]  
BOWER C, 2005, REPORT BIRTH DEFECTS
[9]  
Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V54, P1301
[10]  
Chaney RH, 2000, MENT RETARD, V38, P289, DOI 10.1352/0047-6765(2000)038<0289:PIMOYA>2.0.CO